Notable healthcare headlines for the week: J&J, GSK, Merck, and Cassava Sciences in focus
https://seekingalpha.com/news/4426717-notable-healthcare-headlines-for-the-week-j-and-j-gsk-merck-and-cassava-sciences-in-focus?source=feed_sector_healthcare
Mar 30, 2025 -
0
GSK wins approval of antibiotic gepotidacin for urinary tract infections
https://seekingalpha.com/news/4424870-gsk-wins-approval-antibiotic-gepotidacin-urinary-tract-infections?source=feed_sector_healthcare
Mar 25, 2025 -
0
GSK to investigate if shingles vaccine can cut dementia risk
https://seekingalpha.com/news/4424843-gsk-investigate-if-shingles-vaccine-can-cut-dementia-risk?source=feed_sector_healthcare
Mar 25, 2025 -
0
Gilead, GSK could be impacted by potential HHS HIV prevention cuts
https://seekingalpha.com/news/4421969-gilead-gsk-could-impacted-potential-hhs-hiv-prevention-cuts?source=feed_sector_healthcare
Mar 18, 2025 -
0
GSK shares rise for seven consecutive sessions
https://seekingalpha.com/news/4419028-gsk-shares-rise-for-seven-consecutive-sessions?source=feed_sector_healthcare
Mar 10, 2025 -
0
GSK plc (GSK) TD Cowen 45th Annual Health Care Conference (Transcript)
https://seekingalpha.com/article/4764250-gsk-plc-gsk-td-cowen-45th-annual-health-care-conference-transcript?source=feed_sector_transcripts
Mar 03, 2025 -
0
GSK wins approval of meningococcal vaccine Penmenvy
https://seekingalpha.com/news/4409375-gsk-wins-approval-meningococcal-vaccine-penmenvy?source=feed_sector_healthcare
Feb 18, 2025 -
0
GSK Stock Up On Q4 Results, Positive Outlook; Plans To Buyback GBP 2 Bln Shares
https://www.rttnews.com/story.aspx?Id=3509593
Feb 05, 2025 - Shares of GSK Plc. were gaining around 6 percent on the London Stock Exchange, as well as in the pre-market activity on the NYSE, after the British drug maker reported Wednesday a higher fourth-quarter results and issued positive outlook for fiscal 2025. The company further raised its sales view for fiscal 2031, and announced dividends and 2 billion pounds share buyback programme.
0
Pharma is hopeful about Trump's second term — here's what to expect for drugmakers
https://www.cnbc.com/2025/01/26/trump-health-care-plan-likely-good-for-pharmaceutical-companies.html
Jan 27, 2025 - Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation and patient access to treatments.
0
European Commission approves products by BeiGene, GSK and Novartis
https://seekingalpha.com/news/4339339-european-commission-approves-products-by-beigene-gsk-and-novartis?source=feed_sector_healthcare
Nov 27, 2024 - European Commission approves TEVIMBRA, Menveo, and ribociclib for cancer and meningococcal disease treatment by BeiGene, GSK, and Novartis.
0